Document is current
Any future updates will be listed below
-
Authors
Kellum, John A. https://orcid.org/0000-0003-1995-2653
Zarbock, Alexander
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 4 August 2025
First Online: 19 August 2025
Declarations
:
: AZ has received consulting fees from Astute-Biomerieux, Baxter, Bayer, Novartis, Guard Therapeutics, AM Pharma, Paion, Fresenius, research funding from Astute-Biomerieux, Fresenius, Baxter, and speaker fees from Astute-Biomerieux, Fresenius, Baxter. MO received funding from Baxter. JAK holds royalties or licenses from CytoSorbents, bioMéríeux and J3RM, holds stock of and is employed by Spectral Medical and has received consulting fees from BioMérieux, AstraZeneca, Bayer, Novartis, Mitsubishi Tenabe and Chugai Pharma.
: Ethical approval was not required.
Free to read: This content has been made available to all.
